Search research articles
Contact Us
Filters
Showing results (121-130 of 231) with videos related to
Page
of 24
Sort By:
Haematologica
|
April 27, 2010
Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype
Santiago Montes-Moreno, Ana-Rosa Gonzalez-Medina, Socorro-María Rodriguez-Pinilla, et al.
The American Journal of Surgical Pathology
|
August 24, 2022
Plasmacytoid Dendritic Cell Dermatosis Associated to Myeloproliferative/Myelodysplastic Neoplasms
Salma Machan, Juan M Alonso-Dominguez, F Javier Sánchez García, et al.
Blood
|
September 23, 2011
PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma
Cristina Gómez-Abad, Helena Pisonero, Carmen Blanco-Aparicio, et al.
Oncotarget
|
December 22, 2017
Mutational profile of primary breast diffuse large B-cell lymphoma
Fernando Franco, Julia González-Rincón, Javier Lavernia, et al.
Haematologica
|
August 22, 2015
Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation
Eleonora Fonte, Andreas Agathangelidis, Daniele Reverberi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 8, 2014
NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
Lina Odqvist, Santiago Montes-Moreno, Roxana E Sánchez-Pacheco, et al.
The American Journal of Surgical Pathology
|
May 31, 2019
Large Cells With CD30 Expression and Hodgkin-like Features in Primary Cutaneous Marginal Zone B-Cell Lymphoma: A Study of 13 Cases
Lucía Prieto-Torres, Rebeca Manso, Deysy Elisabeth Cieza-Díaz, et al.
Haematologica
|
February 6, 2010
Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma
Magdalena B Wozniak, Raquel Villuendas, James R Bischoff, et al.
Blood
|
January 4, 2003
Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations
Francisca I Camacho, Patrocinio Algara, Antonia Rodríguez, et al.
Cancer Research
|
April 6, 2007
A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis
Soledad R Alonso, Lorraine Tracey, Pablo Ortiz, et al.
Page
of 24
Search research articles
Search
Showing results (121-130 of 231) with videos related to
Sort By:
Page
of 24
Haematologica
|
April 27, 2010
Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype
Santiago Montes-Moreno, Ana-Rosa Gonzalez-Medina, Socorro-María Rodriguez-Pinilla, et al.
The American Journal of Surgical Pathology
|
August 24, 2022
Plasmacytoid Dendritic Cell Dermatosis Associated to Myeloproliferative/Myelodysplastic Neoplasms
Salma Machan, Juan M Alonso-Dominguez, F Javier Sánchez García, et al.
Blood
|
September 23, 2011
PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma
Cristina Gómez-Abad, Helena Pisonero, Carmen Blanco-Aparicio, et al.
Oncotarget
|
December 22, 2017
Mutational profile of primary breast diffuse large B-cell lymphoma
Fernando Franco, Julia González-Rincón, Javier Lavernia, et al.
Haematologica
|
August 22, 2015
Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation
Eleonora Fonte, Andreas Agathangelidis, Daniele Reverberi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 8, 2014
NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
Lina Odqvist, Santiago Montes-Moreno, Roxana E Sánchez-Pacheco, et al.
The American Journal of Surgical Pathology
|
May 31, 2019
Large Cells With CD30 Expression and Hodgkin-like Features in Primary Cutaneous Marginal Zone B-Cell Lymphoma: A Study of 13 Cases
Lucía Prieto-Torres, Rebeca Manso, Deysy Elisabeth Cieza-Díaz, et al.
Haematologica
|
February 6, 2010
Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma
Magdalena B Wozniak, Raquel Villuendas, James R Bischoff, et al.
Blood
|
January 4, 2003
Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations
Francisca I Camacho, Patrocinio Algara, Antonia Rodríguez, et al.
Cancer Research
|
April 6, 2007
A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis
Soledad R Alonso, Lorraine Tracey, Pablo Ortiz, et al.
Page
of 24